Scientific Instrumentation @ Wyss Collaboratories Program

The Scientific Instrumentation @ Wyss Collaboratories Program is a unique collaboration between industry manufacturers and Wyss scientists and engineers, designed to drive progress, spur entrepreneurship, and incubate innovation. One of the Wyss Institute’s greatest strengths is its position as a collaborative hub – linking academia, hospitals, government, regulatory agencies, philanthropic organizations, and industry to confront global challenges together. The Instrumentation Program engages this extended consortium, offering access to cutting-edge instruments and novel applications that drive breakthrough solutions for healthcare and the environment.

The program is built on the principle of concurrent engineering: developing transformative technologies in parallel with the instruments required to move them forward. Researchers at the Wyss are uniquely positioned to prototype and build emerging technologies, supported by onsite engineering capabilities including a machine shop, makerspace, and state of the art laboratory facilities. Within this environment, and through iterative collaboration with Instrumentation Program participants, we can accelerate discovery – streamlining development and shortening time to market.

Instrumentation Program Participants

Since the launch of the Scientific Instrumentation @ Wyss Collaboratories program in 2023, we are now working with multiple scientific instrument manufacturers to drive impact and innovation.

• Agilent is advancing important research and testing, creating some of the world’s most leading-edge technology and working side by side with customers to help them maximize productivity.
• BioDot specializes in low volume fluid dispensing systems for product development and manufacturing in the diagnostic and life sciences industries.
• Countable Labs has developed single-molecule PCR technology that delivers unbiased, lossless quantification, enabling earlier detection and richer biomarker panels to bridge genomic discoveries into practical clinical assays.
• Portal Bio is a cell engineering platform company focused on enabling next generation cell engineering and drug discovery across research and clinical applications.
• Ramona is advancing human health through live imaging that delivers unrivaled precision and scale.
• SCIEX advances in human wellness depend on the power of precise science. SCIEX empowers customers to solve the most impactful analytical challenges in quantitation and characterization.
• Tecan is dedicated to improving lives and health by empowering customers to scale healthcare innovation globally – from life sciences to clinical applications.
• UpNano leads in high-resolution 3D printing, using innovative 2-photon polymerization (2PP) to precisely fabricate micro- and nanostructures for a wide range of applications. The UpNano printer at the Wyss is the only 2PP 3D printer in the Northeastern United States equipped with an integrated bio-incubator, enabling researchers to directly print living cells and tissues under controlled conditions.
• Waters advances scientific discovery and improves lives by providing innovative analytical solutions that empower customers to solve complex challenges in health, food safety, and the environment.

Outcomes & Recognition

• Inclusion in novel applications that will create new market opportunities in diagnostics, medical devices, therapeutics, and sustainability; captured in published papers and relevant application notes.
• Education of future entrepreneurs and potential industrial customers as they transition from academic labs to new startup companies that will build out labs and scale facilities.
• Presence at the annual Wyss Retreat, a premier event that brings together industry, academia, and future pioneers, including right of first refusal for limited retreat sponsorship opportunities.
• Mention in relevant Wyss publications including the Wyss Annual Impact Report; internal visibility and wall signage (applicable to loans, services, and funding that equal or surpass a $2M value to the Institute).
• Opportunities to be featured in Wyss-created content.
• Donations of equipment qualify for tax deductions, offering a meaningful return on investment while advancing transformative research.